Dr. Keith Vossel, Neurologist and Director of the UCLA Mary S. Easton Center for Alzheimer’s Research and Care, was interviewed by MarketWatch on May 3, 2023, about his perception of a new groundbreaking Alzheimer’s medication, donanemab, by Eli Lilly, and on the unknown costs associated with the new drug and related tests.
